IFF to sell Pharma Solutions business to Roquette for US$ 2.85 billion
Pharma Solutions operates 10 research and development and/or production sites globally
Pharma Solutions operates 10 research and development and/or production sites globally
The proposed acquisition consideration represents an equity value for Myovant of $2.4 billion and an enterprise value of $2.5 billion.
Subscribe To Our Newsletter & Stay Updated